InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Acrivon Therapeutics, Inc.

ACRV Clue Score43
United States Fiscal year ends December CIK 0001781174 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Mary Miller
22 Oct 2026
Chief Legal Officer
Sell
513
$1.84
$943.92
Mary Miller
5 Oct 2026
Chief Legal Officer
Sell
294
$1.99
$585.06
Peter Blume-Jensen
25 Aug 2026
President and CEO
Sell
14,036
$2.21
$30.97K
Peter Blume-Jensen
18 Aug 2026
President and CEO
Sell indirect
484
$2.01
$972.84
Peter Blume-Jensen
18 Aug 2026
President and CEO
Sell
1,229
$2.01
$2.47K
Eric Devroe
18 Aug 2026
Chief Operating Officer
Sell
604
$2.01
$1.21K
Erick Gamelin
18 Aug 2026
Chief Development Officer
Sell
400
$2.01
$804.00
Mary Miller
18 Aug 2026
Chief Legal Officer
Sell
185
$2.01
$371.85
Katharine Peterson
18 Aug 2026
Chief Accounting Officer
Sell
101
$2.01
$203.01
Adam D. Levy
4 Aug 2026
Chief Financial Officer
Sell
1,142
$1.57
$1.79K
Mary Miller
21 Jul 2026
Chief Legal Officer
Sell
573
$1.76
$1.01K
Adam D. Levy
14 Jan 2026
Chief Financial Officer
Buy
8,832
$1.70
$15.00K
Peter Blume-Jensen
14 Jan 2026
President and CEO
Buy
49,000
$1.68
$82.12K
Eric Devroe
13 Jan 2026
Chief Operating Officer
Buy
10,000
$1.72
$17.22K

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 4,614,977
History held since 16 Nov 2022